Please login to the form below

Not currently logged in
Email:
Password:

Philip Payne completes Concept Life Sciences’ leadership team

He joins as chief commercial officer

Philip PayneIntegrated drug discovery and analytical company, Concept Life Sciences has appointed Philip Payne as its chief commercial officer, completing the group’s leadership line up.

Payne will work with Concept’s executive team and board to drive the group’s commercial strategy, leading the business development function and helping to guide the next stage of the company’s growth.

He will manage the sales team, including identification of new service areas, geographies and markets, supporting the broadening of Concept’s reach into Europe and the US.

He said: “I am excited to join Concept at this pivotal stage in the growth of the company, and look forward to working with the team to meet the group’s commercial and strategic objectives.”

Following 27 years’ experience Payne’s expertise lies in managing business integration development and pharma and biotech analytical and development services.

He joins from Aptuit, where he held various roles including vice president of sales and was responsible for the global business development team and strategic accounts.

Prior to this, he was business development director Europe and Asia for Sterile Technologies at Catalent Pharma Solutions.

Michael Fort, executive chairman, Concept Life Sciences, said: “Philip’s experience in managing multidisciplinary, international teams across a range of industries will be a great asset as Concept’s rapid rate of expansion continues.

“We are delighted to welcome Philip to the group.”

31st October 2017

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics